Yoshinori Moriyama

Yoshinori Moriyama


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2017 in Purinergic Signalling
Verified
Journal Article
Closed access
PDF file
YMYoshinori Moriyama
Yoshinori Moriyama
MHMiki Hiasa
Miki Hiasa
SSShohei Sakamoto
Shohei Sakamoto
HOHiroshi Omote
Hiroshi Omote
MNMasatoshi Nomura
Masatoshi Nomura

1 December 2020 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Open access
YMYoshinori Moriyama
Yoshinori Moriyama
RHRyo Hatano
Ryo Hatano
SMSatomi Moriyama
Satomi Moriyama
SUShunsuke Uehara
Shunsuke Uehara
The solute carrier 18B1 (SLC18B1) is the most recently identified gene of the vesicular amine transporter family and is conserved in the animal kingdom from insects to humans. Proteoliposomes containing the purified human SLC18B1 protein transport not only monoamines, but also polyamines, such as spermidine (Spd) and spermine (Spm), using an electrochemical gradient of H+ established by vacuolar H+-ATPase (V-ATPase) as the driving force. SLC18B1 gene knockdown abolished the exocytosis of polyamines from mast cells, which affected the secretion of histamine. SLC18B1 gene knockout decreased polyamine levels by ~20% in the brain, and impaired short- and long-term memory. Thus, the SLC18B1 protein is responsible for the vesicular storage and release of polyamines, and functions as a vesicular polyamine transporter (VPAT). VPAT may define when, where, and how polyamine-mediated chemical transmission occurs, providing insights into the more versatile and complex features of amine-mediated chemical transmission than currently considered.

1 January 2018 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
YMYoshinori Moriyama
Yoshinori Moriyama
MNMasatoshi Nomura
Masatoshi Nomura

1 March 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YHYuika Harada
Yuika Harada
YKYuri Kato
Yuri Kato
TMTakaaki Miyaji
Takaaki Miyaji
HOHiroshi Omote
Hiroshi Omote
YMYoshinori Moriyama
Yoshinori Moriyama
MHMiki Hiasa
Miki Hiasa
Neutrophils migrate to sites infected by pathogenic microorganisms. This migration is regulated by neutrophil-secreted ATP, which stimulates neutrophils in an autocrine manner through purinergic receptors on the plasma membrane. Although previous studies have shown that ATP is released through channels at the plasma membrane of the neutrophil, it remains unknown whether it is also released through alternate secretory systems involving vesicular mechanisms. In this study, we investigated the possible involvement of vesicular nucleotide transporter (VNUT), a key molecule for vesicular storage and nucleotide release, in ATP secretion from neutrophils. RT-PCR and Western blotting analysis indicated that VNUT is expressed in mouse neutrophils. Immunohistochemical analysis indicated that VNUT mainly colocalized with matrix metalloproteinase-9 (MMP-9), a marker of tertiary granules, which are secretory organelles. In mouse neutrophils, ATP release was inhibited by clodronate, which is a potent VNUT inhibitor. Furthermore, neutrophils from VNUT−/− mice did not release ATP and exhibited significantly reduced migration in vitro and in vivo. These findings suggest that tertiary granule-localized VNUT is responsible for vesicular ATP release and subsequent neutrophil migration. Thus, these findings suggest an additional mechanism through which ATP is released by neutrophils.

1 March 2021 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
KTKeita Tatsushima
Keita Tatsushima
NHNao Hasuzawa
Nao Hasuzawa
LWLixiang Wang
Lixiang Wang
MHMiki Hiasa
Miki Hiasa
SSShohei Sakamoto
Shohei Sakamoto
MNMasatoshi Nomura
Masatoshi Nomura

7 December 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
YMYoshinori Moriyama
Yoshinori Moriyama
NHNao Hasuzawa
Nao Hasuzawa
MNMasatoshi Nomura
Masatoshi Nomura
Vesicular nucleotide transporter (VNUT), an active transporter for nucleotides in secretory vesicles, is responsible for the vesicular storage of ATP and plays an essential role in purinergic chemical transmission. Inhibition of VNUT decreases the concentration of ATP in the luminal space of secretory vesicles, followed by decreased vesicular ATP release, resulting in the blockade of purinergic chemical transmission. Very recently, Miyaji and colleagues reported that eicosapentaenoic acid (EPA) is a potent VNUT inhibitor and effective in treating neuropathic and inflammatory pain and insulin resistance through inhibition of vesicular storage and release of ATP. However, our validation study indicated that, in bovine adrenal chromaffin granule membrane vesicles, EPA inhibited the formation of an electrochemical gradient of protons across the membrane with the concentration of 50% inhibition (IC50) being 1.0 μM without affecting concanamycin B-sensitive ATPase activity. Essentially, similar results were obtained with proteoliposomes containing purified vacuolar H+-ATPase. Consistent with these observations, EPA inhibited the ATP-dependent uptakes of ATP and dopamine by chromaffin granule membrane vesicles, with ID50 being 1.2 and 1.0 μM, respectively. Furthermore, EPA inhibited ATP-dependent uptake of L-glutamate by mouse brain synaptic vesicles with ID50 being 0.35 μM. These results indicate that EPA at sub-μM acts as a proton conductor and increases proton permeability across the membrane, regardless of the presence or absence of VNUT, thereby inhibiting non-specifically the vesicular storage of neurotransmitters. Thus, EPA may affect a broader range of chemical transmission than proposed.